Fig. 5From: Global retrospective analysis of clinician- and patient-reported clinical characteristics and humanistic burden of patients with gastroesophageal cancers on first-line treatmentDrivers of EQ-5D-3L utility index scores in patients with GC/GEJC/EAC, HER2 negative/unknown, on first-line treatment. BMI, Body Mass Index; EAC, esophageal adenocarcinoma; ECOG, Eastern Cooperative Oncology Group; EQ-5D-3L, EuroQol 5-Dimension 3-Level Questionnaire; GC, gastric cancer; GEJC, gastroesophageal junction cancer. * p < 0.05, †base category. Respiratory symptoms include chest infection, shortness of breath, chest pain, persistent coughing, pleural effusion, sputum. Other symptoms include weakness and fatigue, jaundice, acute bleeding, headaches, anemia, other pain, otherBack to article page